ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 445 out of 3593

$987K Total Retail Price of All Prescriptions

Rank: 134 out of 3593

834 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 834 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 834 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,939 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 757 699 1 4
SIMVASTATIN 496 465 2 1
OMEPRAZOLE 398 324 3 5
HYDROCODONE-ACETAMINOPHEN 295 219 S3 4 7
AMLODIPINE BESYLATE 240 213 5 3
LISINOPRIL 240 219 5 2
ZOLPIDEM TARTRATE 239 206 7 12
METOPROLOL TARTRATE 228 206 8 8
HYDROCHLOROTHIAZIDE 218 196 9 10
METFORMIN HCL 199 191 10 6
PRAVASTATIN SODIUM 192 180 11 13
FUROSEMIDE 191 183 12 9
TRAMADOL HCL 186 162 13 17
GABAPENTIN 153 141 14 16
MELOXICAM 147 140 15 29
METOPROLOL SUCCINATE 134 134 16 19
POTASSIUM CHLORIDE 116 102 17 24
ATENOLOL 113 107 18 11
CARVEDILOL 102 97 19 23
FLUOXETINE HCL 98 78 20 60
ATORVASTATIN CALCIUM 94 89 21 15
CLOPIDOGREL 93 84 22 30
LOVASTATIN 88 73 23 20
SYNTHROID 88 83 23 51
TAMSULOSIN HCL 86 81 25 33
ALENDRONATE SODIUM 85 82 26 22
CITALOPRAM HBR 84 53 27 25
LOSARTAN POTASSIUM 84 82 27 14
CYMBALTA 82 65 29 73
NEXIUM 82 70 29 36
PANTOPRAZOLE SODIUM 79 73 31 45
WARFARIN SODIUM 79 76 31 18
NAMENDA 76 68 33 50
ISOSORBIDE MONONITRATE ER 75 71 34 61
CRESTOR 73 72 35 21
GLIPIZIDE 69 69 36 40
MORPHINE SULFATE ER 68 20 S2 37 108
LOSARTAN-HYDROCHLOROTHIAZIDE 66 66 38 48
OXYCODONE HCL-ACETAMINOPHEN 65 25 S2 39 82
PLAVIX 62 59 40 42
DIGOXIN 61 61 41 58
SERTRALINE HCL 61 47 41 28
ESTRADIOL 61 61 R 41 174
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 58 44 26
CELEBREX 57 49 45 100
PAROXETINE HCL 55 46 46 62
FENTANYL 52 20 S2 47 137
BENICAR 52 51 47 131
LYRICA 51 44 49 105
CIPROFLOXACIN HCL 50 42 50 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.